{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-003234","form_type":"8-K","ticker":"SMTI","cik":"0000714256","company_name":"Sanara MedTech Inc.","filed_at":"2025-01-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.150695+00:00","generated_at":"2026-05-27T21:24:40.605424+00:00","sec_items":["1.01","8.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Sanara MedTech acquires exclusive U.S. rights to OsStic fracture product; invests up to €8M for 12.5% of BMI","bullets":["Exclusive U.S. license/distribution for OsStic and ARC delivery tech; initial five-year term with renewal options.","Sanara invests up to €8M (€4M initial incl. debt conversion) for ~12.5% equity in BMI; remaining €4M tied to milestones.","OsStic received FDA Breakthrough Device Designation Dec 2023; U.S. market launch expected Q1 2027.","Targets >100,000 annual periarticular fracture procedures; complements existing surgical portfolio.","Company's Chief Corporate Development Officer Tyler Palmer appointed to BMI board."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-003234","json":"https://secwatch.observer/filing/0001493152-25-003234.json","markdown":"https://secwatch.observer/filing/0001493152-25-003234.md","text":"https://secwatch.observer/filing/0001493152-25-003234.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/714256/000149315225003234/0001493152-25-003234-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/714256/000149315225003234/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T21:24:40.605424+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}